Cargando…
Ursodeoxycholic acid in the management of symptomatic gallstone disease: systematic review and clinician survey
BACKGROUND: Symptomatic gallstones are common. Ursodeoxycholic acid (UDCA) is a bile acid that dissolves gallstones. There is increasing interest in UDCA for symptomatic gallstones, particularly in those unfit for surgery. METHOD: A UK clinician survey of use and opinions about UDCA in symptomatic g...
Autores principales: | Hall, Lewis, Halle-Smith, James, Evans, Richard, Toogood, Giles, Wiggins, Tom, Markar, Sheraz R, Kapoulas, Spyros, Super, Paul, Tucker, Olga, McKay, Siobhan C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035564/ https://www.ncbi.nlm.nih.gov/pubmed/36952251 http://dx.doi.org/10.1093/bjsopen/zrac152 |
Ejemplares similares
-
Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012) -
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)
por: Boerlage, Thomas C. C., et al.
Publicado: (2017) -
Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery
por: Haal, Sylke, et al.
Publicado: (2022) -
Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: A systematic review
por: Jamel, Sara, et al.
Publicado: (2019) -
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial)
por: Haal, Sylke, et al.
Publicado: (2020)